-

BiomedicalTechnologies srl  will submit the maincongress program for accreditation by the European Accreditation Council forContinuing Medical Education (EACCME). To receive the CME credits, you will beasked to complete an online questionnaire. After completing the questionnaire,you will receive your certificate directly from Biomedical Technologies srl

• Medical_Professionals
• Medical_students
• Nurses

• Certificate_of_Attendance
• Badges_Provided
• No_Smoking

More Info

RegistrationDesk

Theregistration desk will be open during the following hours:

Certificateof attendance (non CME/CPD)

Certificatesof attendance will be available for all participants and may be collected at theRegistration Desk on Saturday, October 20, 2016

Liability& Insurance

TheCongress Secretariat and Organizers cannot accept responsibility whatsoever forinjury or damage involving persons and property either during or indirectlyarising from the congress. Participants are advised to make their ownarrangements with respect to personal health and travel insurance.

Clothing

Businesscasual for all occasions

Travel& Visa

Participantsrequiring a visa for entry to Russia are strongly advised to file theirapplication at least 3 months before the intended date of travel. If in doubt,information can be obtained from your nearest Russian Embassy orConsulate, or from your travel agency. There will be an option to apply for avisa during the registration process, which will be handled by our agent

Dear Friends,

We are pleased to announce that the 3rd Congress on Controversies in Thrombosis and Hemostasis (CiTH) will be held in collaboration with the Russian Scientific Society of Clinical Hemostasiology in Moscow, Russia, October 20-22, 2016.

The 3rd edition of this ‘concept congress’ will continue to deal with controversial issues in the field, in the format of debates and discussions allowing ample time for speaker-participant interaction. By attending the congress participants will have the opportunity to attend two congresses in one, as the 2016 CiTH Congress will be held jointly with the VIIIth Russian Conference on Clinical Hemostasis and Hemorheology (www.cith2016.ru). All sessions will be simultaneously translated from/to Russian and English.

Congresses are becoming more and more specialized and monothematic, allowing limited time to fully discuss clinical meaning and the line between Evidence Based Medicine (EBM) and working theories or ideas that are premature to implement into practice. CiTH addresses this need by facilitating effective debate on unresolved clinical and therapeutic dilemmas, supported by expert opinions resulting in agreement on timely issues.

The ability to discuss controversial topics with emphasis on clinical solutions in cases where no agreed-upon answers exist provides clinicians with an insight and a take-home message that ameliorates treatment in the most difficult situations.

We would like to invite you to join us in shaping a provocative program, and look forward to welcoming you to the exciting city of Moscow.

Sincerely,

Congress Chairpersons

Benjamin Brenner, Israel
Rambam Medical Center

Marco Cattaneo, Italy
University of Milan

Anna Falanga, Italy
Hospital Papa Giovanni XXIII

Kathelijn Fischer, Netherlands
University Medical Center Utrecht

Jean Gris, France
University Hospital of Nîmes

Gili Kenet, Israel
Tel Aviv University

Ton Lisman, Netherlands
University Medical Center Groningen

Aharon Lubetsky, Israel
Sheba Medical Center

Pier M.Mannucci, Italy
Hospital Cà Granda

Alan Michelson, USA
Harvard Medical School

Paolo Prandoni, USA
University of Padua

Shoshana Revel-Vilk, Israel
Hadassah Medical School

Elena Santagostino, Italy
Hospital Cà Granda

Peter Verhamme, Belgium
University of Leuven

Heleen Van Ommen, Belgium
University of Leuven

David Varon, Israel
Hebrew University Medical Center

EUR

More Info:

Accompanying persons not allowed

Writing an Abstract

Abstractsshould be submitted in English and contain no more than 3,600 characters,including titles, graphs and non-visible characters, such as spaces and linebreaks.

Pleasewrite concisely and clearly and follow this structure:

  Problemstatement: Why do we care about the problem?

  Methods:What did you actually do to get your results?

  Results:What did you learn/invent/create?

  Conclusion:What are the implications of your findings?

Pleaseensure that your abstract does not contain spelling, grammar or scientificmistakes, as it will be reproduced exactly as submitted. No proof reading willbe done. Linguistic accuracy is the responsibility of the submitter.

Images/graphs/tables canbe uploaded according to the following criteria:

• Width (in pixels): min 50 / max 750
• Height (in pixels): min 50 / max 750
• Size (in KB): min 20/ max 1,000
• Resolution (dpi): min 96 / max 300. The standard display size for images is 96 dpi.
• Format: JPG, PNG or GIF

You mayimprove the quality of your image for publication by increasing the number ofdpi as well as the height and width of the image (in pixels).
If you wish to modify your image, you may use the programme Paint.Net (freesoftware).

Abstractsubmissions that do not meet the above noted guidelines may be rejected withoutreview.

TheScientific Committee may request additional information about abstracts andreject abstracts.

Type of Presentation

Authorsshould select their presentation preference. Final decision on the presentationtype will be made by the Scientific Committee.

Oralpresentation: Theabstract is selected for oral presentation at any of the Free Communicationsessions. –> Note: The number of oral presentations is limited. Abstractswith preference for oral presentation will be selected by the Scientificcommittee.

Posterpresentation: Theabstract is selected for presentation in a Poster format. Posters will be ondisplayed throughout the meeting.
Book only: The submitter chooses not to present the abstract in oral orposter format. The abstract will only appear in the Abstract Book.

Important Information

• Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).
• Creation of a user account is required for the submission of an abstract.
• Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance.  If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.
• The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.

Aftersubmission

• Submitting authors will be notified as to whether their abstract has been accepted, as well as the date, time and form of their presentation.
• Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
• If the original presenting author is unable to present the abstract, it is that person’s responsibility to ensure that one of the co-authors takes over this role.
• It is the duty of the original presenting author to advise the Congress Secretariat (cith@congressmed.com) in writing of his successor’s full name and email address.

If you are registered, You can upload your abstract here or through you Account by adding this event to favorites

Submission Info

Writing an Abstract

Abstractsshould be submitted in English and contain no more than 3,600 characters,including titles, graphs and non-visible characters, such as spaces and linebreaks.

Pleasewrite concisely and clearly and follow this structure:

  Problemstatement: Why do we care about the problem?

  Methods:What did you actually do to get your results?

  Results:What did you learn/invent/create?

  Conclusion:What are the implications of your findings?

Pleaseensure that your abstract does not contain spelling, grammar or scientificmistakes, as it will be reproduced exactly as submitted. No proof reading willbe done. Linguistic accuracy is the responsibility of the submitter.

Images/graphs/tables canbe uploaded according to the following criteria:

• Width (in pixels): min 50 / max 750
• Height (in pixels): min 50 / max 750
• Size (in KB): min 20/ max 1,000
• Resolution (dpi): min 96 / max 300. The standard display size for images is 96 dpi.
• Format: JPG, PNG or GIF

You mayimprove the quality of your image for publication by increasing the number ofdpi as well as the height and width of the image (in pixels).
If you wish to modify your image, you may use the programme Paint.Net (freesoftware).

Abstractsubmissions that do not meet the above noted guidelines may be rejected withoutreview.

TheScientific Committee may request additional information about abstracts andreject abstracts.

Type of Presentation

Authorsshould select their presentation preference. Final decision on the presentationtype will be made by the Scientific Committee.

Oralpresentation: Theabstract is selected for oral presentation at any of the Free Communicationsessions. –> Note: The number of oral presentations is limited. Abstractswith preference for oral presentation will be selected by the Scientificcommittee.

Posterpresentation: Theabstract is selected for presentation in a Poster format. Posters will be ondisplayed throughout the meeting.
Book only: The submitter chooses not to present the abstract in oral orposter format. The abstract will only appear in the Abstract Book.

Important Information

• Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).
• Creation of a user account is required for the submission of an abstract.
• Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance.  If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.
• The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.

Aftersubmission

• Submitting authors will be notified as to whether their abstract has been accepted, as well as the date, time and form of their presentation.
• Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
• If the original presenting author is unable to present the abstract, it is that person’s responsibility to ensure that one of the co-authors takes over this role.
• It is the duty of the original presenting author to advise the Congress Secretariat (cith@congressmed.com) in writing of his successor’s full name and email address.

Abstract submission opens 2015-12-05

Abstract submission deadline 2016-06-15

Young Scientist Award

Who is eligible to enter?

Physicians, scientists & researchers born in 1981 or after

What is this competition all about?

The Scientific Committee of the Congress on Controversies in Thrombosis and Hemostasis (CiTH) invites young scientists or researchers to submit their work and to join the Young Scientist Award competition.

The winner(s) will receive free registration and the abstract will be presented as an oral presentation.

Wow! 

How do I enter?

It’s very simple.

1. Submit your abstract via the Congress website no later than June 15, 2016. (http://congressmed.com/cith/call-for-abstracts/)

2. Register and pay registration fees (If your abstract is selected as a winner, your full registration fees will be refunded).

3. Include your date of birth during the registration process.

Great! So what are the guidelines for submitting?

Submitters must be born in 1981 or after.

Submitters must be the first author of the abstract.

Attendance at the CiTH Congress by the winner is mandatory in order to receive and collect the award.

Winner(s) who cancel for any reason will not be entitled to collect their award.

Note that abstracts sent by email or fax will automatically be rejected.

The organizing committee reserves the right to change the conditions

at any time without notice

A professional exhibition will take place within the framework of the congress.

For details regarding exhibition space or sponsorship opportunities please contact the Secretariat.

CiTH Secretariat

CongressMed

E-mail:industry@congressmed.com

Congress Secretariat

Tel. +41 22 33 99 985

Fax. +972 3 725 6266

E-mail: cith@congressmed.com

Registration

Tel. +41 22 33 99 576

Fax. +41 22 33 99 631

E-mail: cith.reghot@mci-group.com

Industry Liaison

Tel. +41 22 33 99 985

Fax. +972 3 725 6266

E-mail: industry@congressmed.com

Abstract

Tel. +41 22 33 99 673

Fax. +41 22 33 99 601

E-mail: cith.abs@mci-group.com